OrthoPediatrics corp

Warsaw, United Stateswww.orthopediatrics.com
Invested through
  • Triodos Future Generations Fund
  • Triodos Impact Strategy Fund - Defensive
  • Triodos Impact Strategy Fund - Balanced
  • Triodos Impact Strategy Fund - Offensive
  • Triodos Impact Strategy Fund - Dynamic
Asset ClassesListed equity
Impact strategyImpact Equities and Bonds
ISIN codeUS68752L1008
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

OrthoPediatrics operates as a medical device company focused exclusively on pediatric orthopedics. It designs, develops, and commercializes orthopedic implants and instruments to improve the lives of children with orthopedic conditions. The company markets over 35 surgical systems serving the three categories within the pediatric orthopedic market mentioned. The company commercializes its products mainly in the US (close to 90% of revenues) and more than 40 countries outside the United States. OrthoPediatrics was founded in 2006 and employs around 120 full-time employees.

Investment rationale

Historically, there have been a limited number of implants and instruments specifically designed for the unique needs of children. As a result, pediatric orthopedic surgeons often improvise with adult implants repurposed for use in children, resort to freehand techniques with adult instruments, and use implants that can be difficult to remove after being temporarily implanted. These improvisations may lead to undue surgical trauma and morbidity given that the bones of children are very different from adults (smaller, with a different composition, still growing so changing shape as well). By developing implants specifically for children, OrthoPediatrics contributes to a better and more mobile future for children that need implants.